Cargando…

Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China

We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Shuli, You, Xuedan, Liu, Tianyi, Wang, Lijiao, Yin, Zheng, Liu, Yanjun, Ye, Chong, Yang, Ting, Huang, Mao, Li, Hongchao, Fang, Liwen, Zheng, Jinping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137942/ https://www.ncbi.nlm.nih.gov/pubmed/34016999 http://dx.doi.org/10.1038/s41533-021-00233-z

Ejemplares similares

Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China
por: Zhang, Jing, et al.
Publicado: (2019)

Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis
por: Hu, Xin, et al.
Publicado: (2019)

Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis
por: Chen, Yahong, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical Trial
por: Hu, Ming, et al.
Publicado: (2022)

REALizing and improving management of stable COPD in China: a multi-center, prospective, observational study to realize the current situation of COPD patients in China (REAL) – rationale, study design, and protocol
por: Yang, Ting, et al.
Publicado: (2020)

Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis
por: Men, Peng, et al.
Publicado: (2020)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
por: Zhang, Jing, et al.
Publicado: (2018)

Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
por: Gong, Shiyi, et al.
Publicado: (2021)

Identifying potentially cost effective chronic care programs for people with COPD
por: Steuten, L M G, et al.
Publicado: (2009)

The national COPD screening programme in China: rationale and design
por: Lei, Jieping, et al.
Publicado: (2023)

Editorial: Osteoporosis, sarcopenia and muscle-bone crosstalk in COPD
por: Sun, Yongchang, et al.
Publicado: (2022)

Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
por: Guo, Lan-Wei, et al.
Publicado: (2020)

Efficacy of a Self-Designed Questionnaire for Community Screening of COPD
por: Yang, Shuang, et al.
Publicado: (2022)

Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
por: Cheng, Shih-Lung, et al.
Publicado: (2021)

Development of a Screening Tool for Common Mental Disorders Among General Hospital Inpatients in China
por: Yuan, Shuai, et al.
Publicado: (2021)

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis
por: Qin, Xiaojian, et al.
Publicado: (2021)

Cost-effectiveness analysis of neonatal hearing screening program in china: should universal screening be prioritized?
por: Huang, Li-Hui, et al.
Publicado: (2012)

The direct cost of "Thriasio" school screening program
por: Grivas, Theodoros B, et al.
Publicado: (2007)

Screening for comorbidities in COPD
por: Natali, Delphine, et al.
Publicado: (2020)

Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians
por: Yan, Xixin, et al.
Publicado: (2017)

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program
por: Bourbeau, Jean, et al.
Publicado: (2019)

Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
por: Wang, Zhenhua, et al.
Publicado: (2022)

558. Cost-effectiveness of Introducing Metagenomic Next-generation Sequencing (mNGS) for the Diagnosis of Suspected Respiratory Infections Patients in China
por: Peng, Siyang, et al.
Publicado: (2023)

Carbocisteine inhibits the expression of Muc5b in COPD mouse model
por: Song, Yan, et al.
Publicado: (2019)

Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis
por: Men, Peng, et al.
Publicado: (2018)

Validity of the Handheld Expiratory Flowmeter for COPD Screening in the Primary Care Setting of China
por: Chen, Shuyun, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer
por: Zheng, Peiyu, et al.
Publicado: (2023)

From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator
por: Divo, Miguel J., et al.
Publicado: (2023)

557. Cost-effectiveness of Introducing Metagenomic Next-generation Sequencing (mNGS) for the Diagnosis of Suspected Neurological Infections Patients in China
por: Peng, Siyang, et al.
Publicado: (2023)

Breast cancer screening with mammography in women aged 40–49 years: Impact of length of screening interval on effectiveness of the program
por: Mao, Zheng, et al.
Publicado: (2020)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program
por: Lee, Hae-Young, et al.
Publicado: (2021)

Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness
por: Chen, Chunlan, et al.
Publicado: (2016)

RESPONDERS TO A PHYSICAL ACTIVITY COACHING PROGRAM IN COPD
por: Nguyen, Huong Q, et al.
Publicado: (2019)

Geographical Disparity and Associated Factors of COPD Prevalence in China: A Spatial Analysis of National Cross-Sectional Study
por: Wang, Ning, et al.
Publicado: (2020)

Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China
por: Huang, Xiao-Mei, et al.
Publicado: (2022)

MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model
por: Huang, Xuan, et al.
Publicado: (2022)

Effect Analysis of Lung Rehabilitation Training in 5A Nursing Mode for Elderly Patients with COPD Based on X-Ray
por: Xu, Peihong, et al.
Publicado: (2022)

Early detection of COPD in primary care -The Copenhagen COPD Screening Project
por: Lyngsø, Anne Marie, et al.
Publicado: (2010)

Cost-effectiveness analysis of a community-based colorectal cancer screening program in Shanghai, China
por: Jiang, Hongli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s22q5dt09ejphsmp1s2bvocafm